Application Deadline: September 1, 2017 @ 11:59 PM EDT (Applications for 2018 will be accepted after July 1, 2017)
Pharmacology/toxicology awards support career development activities of scientists embarking on research that integrates information on molecular or cellular mechanisms of action with information on the effects of an agent observed in an intact organism, in experimental animal or clinical studies or both.
Highest priority will be given to applicants whose research will attempt to integrate information on a drug or chemical’s mechanism of action at the molecular or cellular level with a drug’s effect in a human or laboratory animal. Applicants should describe the significance of a hypothesis being tested in the context of potential influences of biochemical, physiological, behavioral, or social systems.
These awards intend to encourage training to apply the perspective of molecular, cell, and systems biology to pharmacology and toxicology research. Their scope includes basic drug action studies, detection of cellular responses to drugs at the gene level that create opportunities to optimize individualized drug therapy, and the corresponding evaluation of pharmaceuticals in human and clinical populations.
- To provide stipend support for individuals engaged in a multidisciplinary research training program that will create or extend their credentials in pharmacology or toxicology.
- To support postdoctoral career development activities that will result in achieving new skills in pharmacologically relevant areas.
Eligibility & Requirements
- Applicants must have a firm commitment from a sponsor/mentor at an accredited U.S. university.
- The awards support candidates proposing to gain new skills in relevant areas. Funding is for up to two years, but not beyond the third year of the existing post doctorate. Applications requesting funds to continue an existing postdoctoral program for a third to fifth year will not be considered, nor will preference be given to those applying for funds to support postdoctoral work in the laboratory where their graduate work was performed.
- While all applications involving pharmacology/toxicology research will be considered, preference will be given to individuals sponsored by a unit with responsibility for pharmacology/toxicology training and research as part of its core mission. If the pharmacology/toxicology mission is not apparent of the sponsoring unit’s website, the sponsor letter must describe how the academic appointment will support the applicant’s career development in pharmacology/toxicology.
- Applicants must hold a Ph.D. or appropriate terminal research doctorate in a field related to the proposed postdoctoral activities or expect to receive such a degree before activating the award.
- All applicants must be U.S. citizens or permanent residents.
- The award is made to the university on behalf of the fellow.
- The fellowship provides a stipend of $40,000 a year payable quarterly.
- Awards may be activated beginning January 1, 2018 or on the first day of any month thereafter, up to and including December 1, 2018.
- This award is intended solely as a stipend and may not be used otherwise. If necessary the institution may supplement the award to a level that is consistent with other postdoctoral fellowships it currently offers.
- The program provides no other subsidies (travel, tuition, fringe benefit costs, etc.)
- PhRMA foundation funds may not be used for indirect costs or fringe benefits.
- The second year of funding, if applicable, will be contingent upon a progress report approved by the Foundation and submission of a financial report.
- These funds are not transferable.
Post Doctoral Fellowship Application Checklist
Please make a copy of this list to reference during the application process, as incomplete applications will not be considered.
- General Registration Information
- Applicant CV or Biosketch
- Extended Letter
This letter is an opportunity to tell us who you are and to describe your career and future plans. Include a synopsis of your career, your professional interests, and your desired career path. The letter should not exceed two single-spaced pages (12-point font).
- Research Plan 
The applicant must prepare a comprehensive statement, not to exceed eight single-spaced pages (12-point font), of the plans for research, education, and training in the selected discipline. Applicants should use a format similar to the format specified for grants submitted to the National Institutes of Health, including a description of the objective(s), the rationale, methods of approach, and a bibliography of major references (bibliographies are not included in the page limit). Preliminary results, if any, should also be included. A project timeline is suggested. The first use of any abbreviation or acronym should be preceded by the full name or description or included in a footnote. The Basic Pharmacology Advisory Committee will review each application to assess the quality of the proposed research, as well as the proposed education and training. Therefore, documentation stating proper guidance and departmental support will be available to ensure training in the techniques and principles of the area is essential. The proposal must document the approval of all departments in which the candidate will train via letters from chairs or mentors in these departments, or from appropriate personnel if the proposal includes an experiential rotation in an industrial research laboratory.
- Research Abstract
Submit a titled abstract of approximately 200 words concerning your proposed research plan.
Unofficial copies of graduate transcripts should be scanned and uploaded along with the application. Arrange to have official hard copies sent to the PhRMA Foundation at 950 F Street, NW, Suite 300, Washington, DC 20004 by the deadline.
Without these transcripts, the application will be considered incomplete. Do not upload secure PDFs, as our reviewers will be unable to open the attachments.
Provide a budget and list any other funding this project receives.
- Department Chair Information and Letter of Reference
a. The chair should provide contact information.
b. Define the pharmacology/toxicology mission of the department.
c. Provide information as to the mechanisms by which the department supports pharmacology/toxicology.
d. Describe explicitly the support the department will provide to the student (e.g. funding, space, etc.).
e. Provide a detailed training plan.
f. Describe the education of the trainee in the discipline of pharmacology/toxicology.
g. The reference letter should include an assessment of the applicant and proposed research. Information on the applicant’s current source of support and any pending applications for stipend support should be provided. If none are pending, please state this.
- Mentor’s Information and Letter of Reference
a. The mentor should provide contact information and a biosketch.
b. Provide specific information as to the past education of the trainee in the discipline of pharmacology/toxicology.
c. Provide a detailed training plan for the applicant.
d. If the applicant does not have a formal background in pharmacology/toxicology, the sponsor must describe how they will obtain such training as a postdoctoral student (e.g. a class, part of a project with a pharmacologist, etc.). This mechanism of training of the applicant must be made clear.
e. The reference letter should include an assessment of the candidate and proposed research.
- Information and Letters of Reference from Up to Three Other Individuals Familiar with Your Scientific Career
Copies of relevant articles published by the applicant should be uploaded to the application.
Letters and third-party materials should not be uploaded by the applicant. The application system will request contact information, including an email address, for your chair, thesis advisor, and additional reference. These individuals will receive a prompt from the system with instructions for uploading their document(s), which will be appended to the application. The deadline date for letters and third-party materials is September 15, 2017.
Based on our policy, we do not provide written reviews.
 Submission of this plan is assurance that the research proposal has been written primarily by the applicant.